Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Addex Therapeutics FY 2024 GAAP EPS CHF (0.05) Down From CHF (0.03) YoY, Sales CHF 404.102K Down From CHF 1.612M YoY

Author: Benzinga Newsdesk | April 25, 2025 01:34am

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of CHF (0.05) per share. This is a 66.67 percent decrease over losses of CHF (0.03) per share from the same period last year. The company reported CHF 404.102 thousand in sales this quarter. This is a 74.93 percent decrease over sales of CHF 1.612 million the same period last year.

Posted In: ADXN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist